Phase 3 randomized study for evaluation of physician choice Rx versus best supportive care as second-line or beyond therapy in head and neck cancer with poor performance status.
- Resource Type
- Academic Journal
- Source
Journal of Clinical Oncology (J CLIN ONCOL), 2024 Supplement 17; 42: LBA6019-LBA6019. (83p)- Subject
- Language
- English
- ISSN
- 0732-183X